These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29650091)

  • 21. Could clinical inertia in part explain the unexpected association of insulin therapy with poorer cardiovascular outcomes in observational studies on diabetes?
    Giorda CB
    Diabetes Res Clin Pract; 2011 Jun; 92(3):e47-8. PubMed ID: 21035888
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of 16-week monotherapy with acarbose on cardiovascular risk factors in obese subjects with non-insulin-dependent diabetes mellitus: a controlled, double-blind comparison study with placebo.
    Calle-Pascual A; Garcia-Honduvilla J; Martin-Alvarez PJ; Calle JR; Maranes JP
    Diabetes Metab; 1996 Jun; 22(3):201-2. PubMed ID: 8697309
    [No Abstract]   [Full Text] [Related]  

  • 23. Influence of glycemic control on the development of diabetic cardiovascular and kidney disease.
    Saha SA; Tuttle KR
    Cardiol Clin; 2010 Aug; 28(3):497-516. PubMed ID: 20621253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: New features and the ‘Ten Commandments’ of the 2019 Guidelines are discussed by Professor Peter J. Grant and Professor Francesco Cosentino, the Task Force chairmen.
    Grant PJ; Cosentino F
    Eur Heart J; 2019 Oct; 40(39):3215-3217. PubMed ID: 31608951
    [No Abstract]   [Full Text] [Related]  

  • 25. Early screening for diabetes mellitus: has it been overstated?
    Boucher FG
    Can Fam Physician; 2004 Nov; 50():1503-4. PubMed ID: 15597968
    [No Abstract]   [Full Text] [Related]  

  • 26. Focus on metformin - a major cardiovascular medication. 'Diabesity - the biggest epidemic in human history'.
    Straughan JL
    Cardiovasc J Afr; 2007; 18(5):331-3. PubMed ID: 17985034
    [No Abstract]   [Full Text] [Related]  

  • 27. [112th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: Emerging Comorbidities of Diabetes Mellitus: Drug Therapy of Diabetes Mellitus to Prevent Complications].
    Inagaki N
    Nihon Naika Gakkai Zasshi; 2015 Sep; 104(9):1912-6. PubMed ID: 30160897
    [No Abstract]   [Full Text] [Related]  

  • 28. How important is diabetes as a risk factor for cardiovascular and other diseases in older adults?
    Kengne AP; Patel A
    PLoS Med; 2006 Oct; 3(10):e424. PubMed ID: 17048981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (10) Older adults.
    American Diabetes Association
    Diabetes Care; 2015 Jan; 38 Suppl():S67-9. PubMed ID: 25537711
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiovascular safety trials: be careful what you wish for.
    Bloomgarden Z; Grunberger G
    J Diabetes; 2014 Jan; 6(1):1-3. PubMed ID: 24103189
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic Medications.
    Alvarez CA; Lingvay I; Vuylsteke V; Koffarnus RL; McGuire DK
    Clin Pharmacol Ther; 2015 Aug; 98(2):145-61. PubMed ID: 25963811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recommendations from the Canadian Diabetes Association. 2003 guidelines for prevention and management of diabetes and related cardiovascular risk factors.
    Harris SB; Lank CN
    Can Fam Physician; 2004 Mar; 50():425-33. PubMed ID: 15318682
    [No Abstract]   [Full Text] [Related]  

  • 33. [Time for a European perspective on cardiovascular prevention].
    Nilsson PM; Perk J; Rydén L
    Lakartidningen; 2008 Apr 2-8; 105(14):1000-4. PubMed ID: 18478749
    [No Abstract]   [Full Text] [Related]  

  • 34. [Do oral antidiabetics play a part in the cardiovascular mortality of diabetics? Apropos of the University Group Diabetes Program report and the controversies it has raised].
    Canivet J; Deuil R; Eschwege E; Hazard J; Lubetzki J; Tchobroutsky G; Valleron A
    Presse Med (1893); 1971 Dec; 79(53):2437-44. PubMed ID: 5156529
    [No Abstract]   [Full Text] [Related]  

  • 35. The Avandia debate.
    Bloomgarden ZT
    Diabetes Care; 2007 Sep; 30(9):2401-8. PubMed ID: 17726191
    [No Abstract]   [Full Text] [Related]  

  • 36. Selection of the Best of 2016 in Diabetes and Heart.
    Cosín-Sales J; Escobar C; Marzal D; Barrios V
    Rev Esp Cardiol (Engl Ed); 2017 Feb; 70(2):124-125. PubMed ID: 28131405
    [No Abstract]   [Full Text] [Related]  

  • 37. [Too positive comment on glitazones].
    Lindberg M
    Ugeskr Laeger; 2007 Feb; 169(8):733; author reply 733. PubMed ID: 17338040
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of older persons with diabetes].
    Fernández MA
    Semergen; 2014 May; 40 Suppl 1():10-6. PubMed ID: 25263638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular effects of some antidiabetic drugs.
    Med Lett Drugs Ther; 2017 Aug; 59(1527):136-138. PubMed ID: 28787745
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rehabilitation of oral hypoglycemic agents].
    Biron P
    Union Med Can; 1975 Sep; 104(9):1421-4. PubMed ID: 1179546
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.